Pfizer earned $27.7B in Q2: 3 findings

In 2022's second quarter, Pfizer reported July 28 its largest-ever quarterly sales as it racked up $27.7 billion, mostly thanks to its vaccine sales. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive